Toronto, May 4th, 2021 – MORSE Consulting is pleased to release their 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) report – a comprehensive source of reimbursement timelines and insights to inform forecasting and planning needs.
MORSE has analyzed Canadian market access data from 2018 through 2020 to produce key reimbursement metrics. The report will support forecasting or planning necessary for launch in Canadian by providing critical insights on the public market reimbursement process – from HTA submission to provincial listing.
Please click here to learn more about our new report.
About the Authors:
MORSE Consulting Inc. is a leader in strategic pharmaceutical market access consulting in Canada. Our team has significant expertise in reimbursement strategy in a wide range of therapeutic areas and has built a reputation for providing meaningful strategic insights. MORSE has established strong, constructive relationships with healthcare stakeholders and a proven track record for delivering impactful results to its clients.
